article thumbnail

FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel

pharmaphorum

Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting tomorrow – but the regulator noted that there are still uncertainties about whether the shot can stop the disease from spreading. The post FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel appeared first on.

Vaccines 111
article thumbnail

How can evidence-based medicine (EBM) methodology support drug withdrawals?

European Pharmaceutical Review

1 But while data on adverse reactions is rightly used to help with these decisions, there is currently no additional modelling on the positive impact regulatory action could have on public health. Researchers also study the long-term effects of medicines and vaccines, as well as the safety of new and advanced products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

COVID-19: Booster Doses, Breakthrough Infections, Delta, and How they Connect

The Infectious Pharmacist

Today I’ll answer some “reader mailbag” questions about COVID-19 vaccine booster doses, breakthrough infections, Delta, and how they all connect. be offering COVID-19 vaccine booster doses? But supply is not the primary issue behind our suboptimal vaccination rates. What about checking for antibodies in vaccinated patients?

article thumbnail

Should You Take Paxlovid If You Catch COVID?

The People's Pharmacy

This week there were over 20,000 people hospitalized with the virus. Patients who tested positive for COVID-19 and were not hospitalized were selected. It didn’t matter whether they were vaccinated and boosted or not. Diarrhea and muscle pain are also possible adverse reactions. Hundreds continue to die daily.

article thumbnail

COVID-19: Booster Doses – Part 3

The Infectious Pharmacist

Pfizer vs. Moderna and a note on vaccine dosing and timing. You probably have read news reports about a preprint article stating that the Moderna vaccine appeared more effective than the Pfizer vaccine, at least several months after vaccination. Should I stick with the same mRNA vaccine I got for the first two doses?

article thumbnail

How advanced technology can streamline the COVID-19 vaccine rollout

pharmaphorum

Zebra Technologies healthcare lead Chris Sullivan discusses the COVID-19 vaccine rollout and how technology can streamline the process to combat new variants. . While the rollout of the COVID-19 vaccine has signified the first signs of light at the end of the tunnel, the reality is that this public health crisis is still far from over.

Vaccines 119
article thumbnail

mRNA-1345 effective against RSV-associated lower respiratory tract infections in older adults

Hospital Pharmacy Europe

The press release relates to the ConquerRSV trial which was a randomised, double-blind trial, designed to evaluate the safety and tolerability of the mRNA-1345 vaccine. This gave a vaccine efficacy of 82.4% (95% CI 34.8 In fact, only 4% of systemic adverse reactions reported for the vaccine were grade 3 or higher (i.e.,